论文信息 - Response to Crizotinib Re-administration After Progression on Lorlatinib in a Patient With ALK-rearranged Non-small-cell Lung Cancer. - 字舞流文

Response to Crizotinib Re-administration After Progression on Lorlatinib in a Patient With ALK-rearranged Non-small-cell Lung Cancer.

S. Matsumoto | K. Goto | Takaaki Sasaki | N. Shinagawa | Y. Hatanaka | H. Mizugaki | Y. Ikezawa | J. Sakakibara‐Konishi | Ryohei Yoshida | Shin-ichi Chiba | H. Kitai | J. Sakakibara-Konishi | Hidenori Kitai